Hong Kong (HSI) Pharmaceuticals & Biotech Dividend Stocks

UPDATED Apr 21, 2024

Discover Hong Kong Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the HSI and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

43 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

1681

Consun Pharmaceutical Group
HK$5.58-2.8%16.3%HK$4.4bHK$7.87PE5.2xE14.4%10.7%

239

Pak Fah Yeow International
HK$2.05-0.5%41.4%HK$638.9mn/aPE6.1xn/a10.0%

2633

Jacobson Pharma
HK$0.57-1.7%-38.7%HK$1.1bn/aPE4.7xn/a8.6%

2161

JBM (Healthcare)
HK$0.91-2.2%-17.3%HK$753.5mn/aPE7.7xn/a7.6%

2348

Dawnrays Pharmaceutical (Holdings)
HK$1.15-4.2%-12.9%HK$1.7bn/aPE4.9xn/a7.0%

512

Grand Pharmaceutical Group
HK$3.97-3.2%-19.5%HK$13.9bn/aPE7.4xE20.0%6.5%

2877

China Shineway Pharmaceutical Group
HK$9.45-2.9%10.3%HK$7.1bHK$14.09PE6.8xE14.5%6.1%

867

China Medical System Holdings
HK$7.00-3.4%-48.1%HK$17.1bHK$12.37PE6.6xE8.9%6.1%

3933

United Laboratories International Holdings
HK$9.59-1.3%53.2%HK$17.4bHK$12.12PE6xE-0.04%5.9%

719

Shandong Xinhua Pharmaceutical
HK$5.25-2.4%-22.9%HK$9.1bn/aPE6.7xn/a5.2%

3737

Zhongzhi Pharmaceutical Holdings
HK$1.20-1.6%-4.8%HK$1.0bn/aPE5.9xn/a5.0%

1093

CSPC Pharmaceutical Group
HK$5.77-2.9%-27.1%HK$68.4bHK$9.35PE10.8xE4.5%4.8%

1530

3SBio
HK$5.56-6.6%-29.2%HK$13.2bHK$7.45PE7.9xE12.6%4.5%

1666

Tong Ren Tang Technologies
HK$4.71-6.7%-38.8%HK$6.0bHK$6.55PE9.4xE4.5%4.1%

1061

Essex Bio-Technology
HK$2.315.0%-37.2%HK$1.3bn/aPE4.8xn/a3.9%

3613

Beijing Tong Ren Tang Chinese Medicine
HK$9.03-1.8%-43.2%HK$7.6bHK$13.93PE14xE15.2%3.7%

1349

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd
HK$2.08-1.4%-35.6%HK$6.1bn/aPE18.3xn/a3.6%

2005

SSY Group
HK$4.71-3.9%-12.6%HK$14.0bHK$6.23PE10.6xE15.0%3.6%

3320

China Resources Pharmaceutical Group
HK$4.791.3%-29.5%HK$30.1bHK$7.41PE7.2xE6.5%3.5%

2096

Simcere Pharmaceutical Group
HK$5.15-1.5%-45.9%HK$13.3bHK$8.64PE17.1xE24.4%3.4%

6826

Shanghai Haohai Biological Technology
HK$37.40-3.6%-10.5%HK$14.7bHK$70.01PE13.9xn/a2.9%

503

Lansen Pharmaceutical Holdings
HK$1.790%23.6%HK$750.6mn/aPE13xn/a2.7%

1177

Sino Biopharmaceutical
HK$2.34-14.3%-47.5%HK$42.9bHK$4.67PE21.5xE15.5%2.1%

3692

Hansoh Pharmaceutical Group
HK$15.38-4.2%6.4%HK$91.1bHK$18.89PE25.7xE8.7%1.8%
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.